February 2016:
       
AD 198 study published in Leukemia Research.


November 2015:
       AD 198 study published in BMC Cancer.

September 2015:
       AD 198 study published in Drug Design, Development and Therapy.


February 2015:
       AD 198 study published in Journal of Cancer Science and Therapy.


March 2014:
       Paradox Pharmaceuticals chosen for TVC semifinals:



June 2014:
       AD 198 study published in Journal of Drug Targeting.



       


​​Innovative therapies
                         Superior outcomes

Previous News